CRYAB and cancer: An increase in the concentration of HSPB5 and its activity under stress play a protective role in the cell, but there are situations when the activity of the chaperone should be reduced, for example, in cancer cells or in the case of pathological protein deposition (cataract and cardiomyopathy) [97].